Alpha-ketoglutarate, commonly sold as AKG, is a naturally occurring molecule your body already makes as part of its core energy-production cycle. As a supplement, it has drawn attention primarily for animal studies suggesting it can extend lifespan and compress the period of age-related decline, along with smaller lines of evidence in bone health, immune function, and exercise performance. The research is genuinely interesting, but the gap between what has been shown in mice and worms and what has been proven in humans remains the central tension for anyone considering buying a bottle.
What AKG Actually Is
AKG is a molecule that sits at a crossroads in your metabolism. It is a key intermediate in the Krebs cycle, the process your mitochondria use to generate energy from food. Beyond just being burned for fuel, AKG serves as a signaling molecule that influences how your cells handle inflammation, how your genes get switched on and off, and how your immune system responds to threats.1PubMed Central. Alpha-Ketoglutarate: A Metabolic Regulator of Cellular Homeostasis and Pathophysiology It can also be converted into glutamine, an amino acid that fuels rapidly dividing cells like those in your gut lining and immune system.2PubMed. The glutamine-alpha-ketoglutarate (AKG) metabolism and its nutritional implications
Your body produces less AKG as you age. Researchers measuring circulating levels in rodents found that aged animals had significantly lower AKG than young adults, which is one reason the molecule caught the attention of aging researchers in the first place.3Nature Communications. Alpha-ketoglutarate ameliorates age-related osteoporosis via regulating histone methylations The logic behind supplementation is straightforward: if declining AKG levels track with aging-related problems, restoring those levels might help.
The Mouse Longevity Study That Started the Hype
The study that put AKG supplements on the map was published in Cell Metabolism in 2020. Researchers fed middle-aged mice a diet containing 2% calcium alpha-ketoglutarate (CaAKG) and tracked them for the rest of their lives. Female mice saw the biggest benefit: median lifespan increased by roughly 10 to 17 percent depending on the cohort, with survival at the 90th percentile extended by up to about 20 percent. Male mice also lived longer on average, with median lifespan up by roughly 10 to 13 percent, though the male results did not reach statistical significance.4PubMed Central. Alpha-Ketoglutarate, an Endogenous Metabolite, Extends Lifespan and Compresses Morbidity in Aging Mice
What made the findings more compelling than a simple lifespan extension was the idea of “morbidity compression.” The CaAKG-fed mice did not just live longer; they spent a smaller fraction of their lives in a frail, declining state. Both males and females showed decreased incidence and severity of aging-related symptoms, and the onset of those symptoms was pushed later. In other words, the mice stayed healthier for a larger proportion of their lives rather than simply lingering in poor health for longer.5PubMed Central. Alpha-Ketoglutarate, an Endogenous Metabolite, Extends Lifespan and Compresses Morbidity in Aging Mice
That same research group also looked at markers of cellular senescence and inflammation. AKG did not appear to prevent cells from becoming senescent, but it reduced the inflammatory signals those senescent cells pump out, including IL-6, IL-1b, and other molecules collectively known as the senescence-associated secretory phenotype. This matters because those inflammatory signals are thought to drive many of the downstream problems of aging, from tissue damage to chronic disease.6Cell Metabolism. Alpha-Ketoglutarate, an Endogenous Metabolite, Extends Lifespan and Compresses Morbidity in Aged Mice
How AKG Might Work at the Cellular Level
The mechanisms researchers have identified so far involve several distinct pathways. One of the best-characterized is AKG’s role as a cofactor for enzymes that modify your epigenome, specifically histone demethylases and a family of enzymes called Tet proteins that participate in DNA demethylation. These enzymes need AKG to function, and their activity determines which genes are accessible and active at any given time.7PubMed Central. The role of α-ketoglutarate-dependent proteins in pluripotency acquisition and maintenance When AKG levels drop with age, these enzymes become less active, which may contribute to the epigenetic drift associated with aging.
A second pathway involves energy sensing. Studies in simple organisms like roundworms and fruit flies have shown that AKG can directly bind to a subunit of the mitochondrial ATP synthase, partially inhibiting it. This reduces ATP production and oxygen consumption, which triggers the cell’s energy-sensing alarm system: mTOR signaling gets dialed down while AMPK activity goes up, and autophagy (the cell’s recycling and cleanup program) increases.8BBA Advances. mTOR/α-ketoglutarate-mediated signaling pathways in the context of brain neurodegeneration and neuroprotection The mTOR pathway is one of the most studied targets in longevity research; inhibiting it is how the drug rapamycin extends lifespan in animal models. So AKG may be tapping into some of the same cellular machinery, though through a different entry point.
AKG also plays a role in regulating a protein called HIF-1α, which orchestrates cellular responses to low oxygen. AKG is required by the enzymes (prolyl hydroxylases) that tag HIF-1α for destruction under normal oxygen conditions. This is relevant because HIF-1α influences everything from blood vessel formation to how tumors behave, making AKG’s relationship with this pathway complex and context-dependent.9PubMed Central. Alpha-Ketoglutarate as a Molecule with Pleiotropic Activity: Well-Known and Novel Possibilities of Therapeutic Use
The Biological Age Study and Its Limitations
One small human study generated headlines claiming AKG could reverse biological aging by eight years. In this retrospective analysis, 42 people took Rejuvant, a commercial formulation containing AKG along with vitamins, for an average of seven months. DNA methylation testing before and after showed an average decrease in biological age of eight years.10PubMed Central. Rejuvant®, a potential life-extending compound formulation with alpha-ketoglutarate and vitamins, conferred an average 8 year reduction in biological aging, after an average of 7 months of use, in the TruAge DNA methylation test
Those results sound dramatic, but the study has significant problems. It was retrospective, meaning researchers looked back at data from people who had already chosen to take the supplement rather than randomly assigning them. There was no placebo control group. The sample was tiny. The formulation included vitamins alongside AKG, making it impossible to attribute the effect to AKG alone. And DNA methylation clocks, while increasingly popular, are still being validated as meaningful proxies for actual health outcomes; a change in your methylation score does not necessarily mean your organs are functioning like a younger person’s.
To address these gaps, a more rigorous trial called ABLE has been designed. It is a double-blinded, placebo-controlled randomized trial testing 1 gram of sustained-release CaAKG per day versus placebo for six months in 120 healthy adults aged 40 to 60 who have elevated DNA methylation age relative to their chronological age.11PubMed Central. Alpha-ketoglutarate supplementation and biological age in middle-aged adults (ABLE)—intervention study protocol This kind of controlled trial is what is needed before anyone can responsibly claim AKG reverses biological aging in humans.
Bone Health Evidence
AKG’s connection to bone goes beyond the longevity angle. The molecule is a required cofactor for prolyl-4-hydroxylase, an enzyme involved in building collagen, which is a major structural component of bone tissue.12PubMed Central. Alpha-Ketoglutarate as a Molecule with Pleiotropic Activity: Well-Known and Novel Possibilities of Therapeutic Use In animal research, supplementing aged mice with AKG improved bone mass, with the mechanism linked to changes in histone methylation patterns that affect how bone cells develop and function.13Nature Communications. Alpha-ketoglutarate ameliorates age-related osteoporosis via regulating histone methylations
There is one small human trial worth noting. Postmenopausal women with reduced bone density took calcium-AKG for six months. By the end of the study, a bone breakdown marker called CTX had dropped by about 37% in the AKG group, a statistically significant decrease. Bone mineral density in the lumbar spine increased by about 1.6% from baseline, though the difference between the AKG group and the control group was small and not statistically significant.14PubMed. Alpha-ketoglutarate decreases serum levels of C-terminal cross-linking telopeptide of type I collagen (CTX) in postmenopausal women with osteopenia: six-month study The results suggest AKG may slow bone loss, but a six-month study in a small group is far from definitive proof, and the authors themselves noted that longer-term data are needed.
AKG and the Immune System
One of the more consistent findings across different AKG studies involves its effects on immune cells, particularly macrophages. These are the immune cells that can swing between a pro-inflammatory state (sometimes called M1 polarization) and an anti-inflammatory, tissue-repair state (M2 polarization). AKG appears to push macrophages toward the anti-inflammatory M2 state.15PubMed Central. The Regulatory Role of α-Ketoglutarate Metabolism in Macrophages
Research on bone regeneration found that AKG reduced pro-inflammatory macrophages in early healing phases and promoted anti-inflammatory macrophages later, with flow cytometry confirming an increased ratio of M2 to M1 macrophages in AKG-treated cells.16Bone Reports. Alpha-ketoglutarate promotes alveolar bone regeneration by modulating M2 macrophage polarization Separate work showed that the signaling pathway behind this involves glutamine metabolism feeding into AKG production, which drives M2 polarization through a specific molecular cascade.17Cell Reports. SENP1-Sirt3 signaling controls αKG accumulation and glutaminolysis in M2 macrophage polarization
This anti-inflammatory skewing could explain part of why AKG-supplemented mice showed reduced systemic inflammatory markers in the longevity study. Chronic low-grade inflammation is a hallmark of aging, and tamping it down is theoretically beneficial. But it is worth noting that immune modulation cuts both ways: a supplement that dials down inflammation is not automatically good if you are fighting an infection or need a robust inflammatory response for some other reason. The practical significance for healthy humans taking AKG daily is still unclear.
The Exercise and Sports Nutrition Angle
You may have encountered AKG not in the longevity space but in sports nutrition, usually combined with the amino acid L-arginine as “AAKG” (arginine alpha-ketoglutarate). This formulation has been marketed as a nitric oxide booster for better blood flow and bigger “pumps” during workouts. The evidence here is mixed at best.
One study in trained men found that AAKG supplementation led to improvements in one-rep-max bench press and peak power output on a cycling sprint test, and it appeared safe and well tolerated. However, it did not change body composition, total body water, muscular endurance, or aerobic capacity.18PubMed. Pharmacokinetics, safety, and effects on exercise performance of L-arginine alpha-ketoglutarate in trained adult men A separate trial looked specifically at blood flow and nitric oxide markers after resistance exercise. While AAKG did raise blood levels of L-arginine, changes in blood flow and nitric oxide metabolites were attributed to the exercise itself, not the supplement.19International Journal of Sport Nutrition and Exercise Metabolism. Effects of 7 Days of Arginine-Alpha-Ketoglutarate Supplementation on Blood Flow, Plasma L-Arginine, Nitric Oxide Metabolites, and Asymmetric Dimethyl Arginine After Resistance Exercise
So the “nitric oxide pump” story behind AAKG in the gym has limited support. The arginine component may raise arginine blood levels, but that does not translate cleanly into better blood flow during training. If you are buying AAKG specifically for workout performance, the evidence suggests modest effects on strength at most, with no meaningful impact on endurance or body composition.
Different Forms on the Market
Supplements labeled “AKG” come in several chemical forms, and the differences matter. Calcium alpha-ketoglutarate (CaAKG) is the form used in the mouse longevity study and in the Rejuvant formulation. It delivers AKG bound to calcium, which means you also get supplemental calcium with each dose. For anyone concerned about bone health, this is a minor plus; for someone already taking calcium supplements, it is worth factoring in to avoid overdoing calcium intake.
Arginine alpha-ketoglutarate (AAKG) is the sports-nutrition form, pairing AKG with L-arginine. Ornithine alpha-ketoglutarate (OKG) pairs it with the amino acid ornithine and has a separate history in clinical nutrition, particularly in burn patients and hospital settings where muscle wasting is a concern. Plain AKG sodium salt also exists but is less common in consumer supplements.
The form matters because the longevity research was conducted with CaAKG specifically. Taking AAKG from a bodybuilding store and expecting the anti-aging effects seen in mice fed CaAKG is a leap the research does not support. The AKG itself may be the active ingredient, but the dosing, absorption, and co-delivered compounds differ between forms.
Dosing and Safety Considerations
The mouse longevity study used a 2% dietary concentration of CaAKG, which is not trivially translated to a human dose. Allometric scaling (adjusting for body size and metabolic rate differences between mice and humans) is imprecise, but most supplement companies have landed somewhere in the range of 300 milligrams to 1 gram per day for their longevity-oriented products. The ABLE clinical trial settled on 1 gram per day of sustained-release CaAKG, which may become a reference point once results are published.20PubMed Central. Alpha-ketoglutarate supplementation and biological age in middle-aged adults (ABLE)—intervention study protocol
AKG is generally considered safe. It is a molecule your body already produces in substantial quantities, and toxicology work, including evaluation as a nebulized formulation for cyanide poisoning treatment, has not raised red flags in healthy volunteers.21PubMed. Development of nano alpha-ketoglutarate nebulization formulation and its pharmacokinetic and safety evaluation in healthy human volunteers for cyanide poisoning The AAKG sports-nutrition studies also reported the supplement was well tolerated.22PubMed. Pharmacokinetics, safety, and effects on exercise performance of L-arginine alpha-ketoglutarate in trained adult men That said, long-term safety data from large human populations simply does not exist yet. Common anecdotal complaints include mild gastrointestinal discomfort, which is not unusual for supplemental organic acids.
Because AKG interacts with energy-sensing and immune pathways, there are theoretical concerns for people with certain conditions. Anyone undergoing cancer treatment should be cautious: AKG’s role as a cofactor for prolyl hydroxylases affects HIF-1α, a factor involved in tumor biology, and its influence on the mTOR pathway adds another layer of complexity.23PubMed Central. Alpha-Ketoglutarate as a Molecule with Pleiotropic Activity: Well-Known and Novel Possibilities of Therapeutic Use The phrase “influences cancer-related pathways” does not mean AKG causes cancer, but it does mean the interaction is poorly understood enough that caution is warranted.
Emerging Research Areas
Beyond longevity and bone health, AKG is being studied in several other contexts. Animal research on chronic kidney disease found that AKG reduced kidney injury, dampened inflammation and fibrosis, and restored mitochondrial structure in affected kidneys. Interestingly, AKG also appeared to reshape the gut microbiome composition in these animals, increasing certain beneficial bacterial populations while decreasing others, and altering the profile of metabolites in the gut.24PubMed. Alpha-ketoglutarate alleviates chronic kidney disease via mitochondrial protection, gut microbiota, and metabolite remodeling This gut-microbiome connection is a newer thread in AKG research and could eventually matter for understanding the systemic effects of supplementation.
In intestinal health specifically, AKG has shown protective effects against oxidative damage. Cell studies demonstrated that AKG shields intestinal cells from hydrogen peroxide damage through a mitochondrial protection mechanism.25PubMed Central. Mitochondrial pathway is involved in the protective effects of alpha-ketoglutarate on hydrogen peroxide induced damage to intestinal cells And research in joint disease has explored whether AKG can reduce cartilage cell aging by lowering reactive oxygen species and supporting mitochondrial function in chondrocytes.26Biochemistry and Biophysics Reports. The research progress of α-ketoglutarate in osteoarthritis
Stem cell researchers have also taken an interest. AKG influences how stem cells differentiate into specialized cell types by modifying the epigenetic landscape. Supplementing with AKG accelerated the early differentiation of human pluripotent stem cells into multiple lineages, while its metabolic competitor succinate slowed that process down.27Cell Metabolism. α-Ketoglutarate Accelerates the Initial Differentiation of Primed Human Pluripotent Stem Cells More recently, AKG was found to promote the development of trophectoderm cells from naive embryonic stem cells by reducing histone acetylation rather than changing overall methylation levels, a mechanism that surprised researchers expecting a methylation-driven effect.28PubMed Central. α-Ketoglutarate promotes trophectoderm induction and maturation from naive human embryonic stem cells This stem cell work is far from the supplement aisle, but it underscores how deeply AKG is woven into fundamental cell biology.
Where the Evidence Honestly Stands
The honest assessment is that AKG is one of the more biologically plausible longevity supplements on the market, but “biologically plausible” and “proven to work in humans” are not the same thing. The mouse data is genuinely striking: the morbidity compression finding, the anti-inflammatory effects, and the consistency with known aging pathways like mTOR give the molecule more scientific backing than most supplements marketed for aging. The handful of human studies that exist are either tiny, uncontrolled, or both. The ABLE trial represents exactly the kind of study the field needs, and until its results arrive, the human evidence remains thin.
If you decide to try AKG, choosing CaAKG rather than AAKG makes sense if your interest is the longevity angle, since that is the form with the relevant animal data. The price is not trivial; sustained-release CaAKG products typically cost considerably more than generic AAKG from sports-nutrition brands. Whether the sustained-release formulation meaningfully changes absorption and efficacy in humans is another open question that has not been rigorously tested. For now, AKG sits in an unusual position: a supplement with a genuinely interesting biological story, reasonable safety data, and a human evidence base that has not yet caught up with the enthusiasm surrounding it.